Healthcare Utilization Amongst Patients with NSCLC Before and After Testing with a Host Immune Classifier (HIC) in a Real-World Setting

被引：0
作者：
Iams, Wade [1 ]
Le, Kimberly [2 ]
Princic, Nicole [3 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Biodesix Inc, Boulder, CO USA
[3] Merative, Ann Arbor, MI USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP01.13
引用
收藏
页码：E13 / E14
页数：2
相关论文
共 50 条
  • [31] Relapse after radiochemotherapy and consolidative Durvalumab in Stage III NSCLC - a retrospective analysis in a real-world setting
    Reitnauer, L.
    Evers, G.
    Christoph, D.
    Brueckl, W.
    Wiesweg, M.
    Glanemann, F.
    Webendoerfer, M.
    Kropf-Sanchen, C.
    Acker, F.
    Schuette, W.
    Hoffknecht, P.
    Kerkhoff, A.
    Mohr, M.
    Lenz, G.
    Frost, N.
    Overbeck, T.
    Sebastian, M.
    Bleckmann, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 229 - 229
  • [32] Healthcare Utilization In Cardiomyopathy Patients Who Had Genetic Testing Before Or After Diagnosis
    Moretz, Chad
    Smith, Elizabeth M.
    Aradhya, Swaroop
    Callis, Tom
    Esplin, Edward
    Hatchell, Kathryn
    Hall, Taryn
    Nussbaum, Robert
    Morales, Ana
    Regalado, Ellen
    Ren, Sheng
    Rojahn, Susan
    Vatta, Matteo
    Murillo, Jaime
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (04) : 571 - 571
  • [33] Early Mortality Associated Factors With Immune Checkpoint Inhibition in Real-World Canadian NSCLC Patients
    Gibson, A.
    Meyers, D.
    Dean, M.
    Stukalin, I.
    Morris, D.
    Bebb, D. G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S348 - S348
  • [34] Demographics And Healthcare Utilization Of Patients With Idiopathic Pulmonary Fibrosis (ipf) In A Real-World Setting: Updated Findings From 277 Patients In The Proof Registry
    Wuyts, W. A.
    Dahlqvist, C.
    Slabbynk, H.
    Schlesser, M.
    Gusbin, N.
    Compere, C.
    Joos, G. F.
    Maddens, S.
    Kolkman, E.
    Kirchgaessler, K. -U.
    Bartley, K.
    Bondue, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [35] HRR testing and PARPi utilization among patients with metastatic castration resistant prostate cancer treated in the real-world setting.
    Vasudevan, Anupama
    Katzen, Harvey I.
    Gart, Mike
    Blanc, Simon
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 91 - 91
  • [36] Ethnic disparities in biomarker testing of patients with metastatic NSCLC in the United States: A real-world analysis
    Jayram, Diya
    Bellur, Shreyas S.
    Ozair, Ahmad
    Ahmad, Shahzaib
    Ganiyani, Mohammad Arfat
    Khosla, Atulya Aman
    McCracken, Andrea
    Marada, Suresh
    Hurmiz, Charlie
    Bowman, Steven, II
    Ahluwalia, Manmeet Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] Treatment Patterns and Overall Survival Following Biomarker Testing in Real-World Advanced NSCLC Patients
    Barlesi, F.
    Paz-Ares, L.
    Page, D.
    Shewade, A.
    Lambert, P.
    Mughal, T.
    Gay, L.
    Khorshid, M.
    Arnieri, B.
    Capra, W.
    Foser, S.
    Mascaux, C.
    Bubendorf, L.
    Wang, L.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S459 - S460
  • [38] Real-World Healthcare Resource Utilization, Healthcare Costs, and Injurious Falls Among Elderly Patients with Geographic Atrophy
    Sarda, Sujata P.
    Germain, Guillaume
    Mahendran, Malena
    Klimek, Jacob
    Cheng, Wendy Y.
    Luo, Roger
    Duh, Mei Sheng
    CLINICAL OPHTHALMOLOGY, 2024, 18 : 3215 - 3226
  • [39] Real-World Treatment Patterns, Healthcare Cost and Resource Utilization in First-Line Treatment of Metastatic NSCLC in the US
    Chopra, D.
    Waterhouse, D. M.
    Sultan, I.
    Lonshteyn, A.
    Delea, T. E.
    Stollenwerk, B.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S400 - S401
  • [40] Treatment patterns and efficacy of durvalumab maintenance after CRT in real-world NSCLC patients
    Taugner, J.
    Kaesmann, L.
    Eze, C.
    Floersch, B.
    Guggenberger, J.
    Tufman, A.
    Reinmuth, N.
    Duell, T.
    Belka, C.
    Manapov, F.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S968 - S968
12345